Results 121 to 130 of about 11,492 (193)

Drug Repurposing for Metabolic-Associated Fatty Liver Disease: Current Evidence, Challenges, and Future Perspectives. [PDF]

Drug Des Devel Ther
Liang X, Jin P, Xue Y, Jia Y, Zhu H, Gong G, Zhou H, Hu H, Lee SM.   +8 more
europepmc   +1 more source

Body Mass Index Outperforms Triglyceride-Glucose Index in Predicting MAFLD in Type 2 Diabetes: A Cross-Sectional Mediation and Interaction Analysis. [PDF]

Diabetes Metab Syndr Obes
Sun Z, Yang L, Wang N, Wang J, Zhu X, Zhou X.   +5 more
europepmc   +1 more source

The association between metabolic dysfunction-associated fatty liver disease and left ventricular mass index in patients with schizophrenia with long-term hospitalization. [PDF]

Front Endocrinol (Lausanne)
Li J, Ma Y, Wang Y, Wu Q.
europepmc   +1 more source

Nonlinear Associations of Estimated Pulse Wave Velocity With Hepatic Steatosis and Liver Stiffness in Community-Based People. [PDF]

Gastroenterology Res
Wang TH, Ru XY, Zhang XX, Fu TT, Yang H, Zhu HR, Pan ZG.   +6 more
europepmc   +1 more source

MicroRNA-122 as a regulator and biomarker of liver disease. [PDF]

J Mol Med (Berl)
Ahmadova S, Wicik Z, Mucha J, Palatini J, Ziętal K, Mirowska-Guzel D, Przybylkowski A, Eyileten C.   +7 more
europepmc   +1 more source

MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD

Metabolic dysfunction-associated fatty liver disease (MAFLD) is the liver manifestation of a metabolic syndrome and is highly prevalent in the general population.
Wong, Vincent Wai-Sun, Nguyen, Mindie H., Chan, Wah-Kheong, Adams, Leon A.   +3 more
core   +1 more source

[Proportion and clinical characteristics of probable metabolic-associated fatty liver disease-related cirrhosis in cryptogenic cirrhosis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang Y, Deng Y, Jian Y, Liu JJ, Zhao YQ, Zhao XY, Zhao JJ, You H.   +7 more
europepmc   +1 more source

Clinical and biochemical phenotypes of Lean MAFLD: machine learning-based biomarker identification and statistical association analysis in a cross-sectional study. [PDF]

Front Public Health
Zhang H, Ji Y, Chen G, Tian Z.
europepmc   +1 more source

The gut-liver axis: microbial mechanisms and therapeutic implications in MAFLD. [PDF]

Front Cell Infect Microbiol
Xue L, Wang H, Shan B, Li C, Chen H, Yu C, Xia C, Zhang H.   +7 more
europepmc   +1 more source

Statin Monotherapy Not Inferior to Aspirin or Combined Aspirin and Statins Reducing the Incidences of Cirrhosis, HCC, and Mortality in MAFLD/MASH Patients: A Population Cohort Study

International Journal of General Medicine
Chern-Horng Lee,1 Yu-Han Huang,2 Tzu-Ju Hsu,3 Tzung-Hai Yen,4 Sen-Yung Hsieh5,6 1Department of Geriatric Medicine and General Internal Medicine, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, 333, Taiwan; 2Department of Management Office for ...
Lee CH, Huang YH, Hsu TJ, Yen TH, Hsieh SY   +4 more
doaj